Does the Bobath/ neurodevelopmental technique (NDT) improve gait quality in acutely post stroke individuals? by Haddad, Victoria
Pacific University
CommonKnowledge
PT Critically Appraised Topics School of Physical Therapy
2015
Does the Bobath/ neurodevelopmental technique
(NDT) improve gait quality in acutely post stroke
individuals?
Victoria Haddad
Pacific University
Follow this and additional works at: http://commons.pacificu.edu/ptcats
Part of the Physical Therapy Commons
Notice to Readers
This work is not a peer-reviewed publication. Though the author of this work has provided a summary of the best available evidence at the time of
writing, readers are encouraged to use this CAT as a starting point for further reading and investigation, rather than as a definitive answer to the clinical
question posed or as a substitute for clinical decision-making.
Select copyrighted material from published articles may be included in this CAT for the purpose of providing a context for an informed critical
appraisal. Readers are strongly encouraged to seek out the published articles included here for additional information and to further examine the
findings in their original presentation. Copyrighted materials from articles included in this CAT should not be re-used without the copyright holder's
permission.
This Critically Appraised Topic is brought to you for free and open access by the School of Physical Therapy at CommonKnowledge. It has been
accepted for inclusion in PT Critically Appraised Topics by an authorized administrator of CommonKnowledge. For more information, please contact
CommonKnowledge@pacificu.edu.
Recommended Citation
Haddad, Victoria, "Does the Bobath/ neurodevelopmental technique (NDT) improve gait quality in acutely post stroke individuals?"
(2015). PT Critically Appraised Topics. Paper 59.
http://commons.pacificu.edu/ptcats/59
Does the Bobath/ neurodevelopmental technique (NDT) improve gait
quality in acutely post stroke individuals?
Disciplines
Physical Therapy
Rights
Terms of use for work posted in CommonKnowledge.
This critically appraised topic is available at CommonKnowledge: http://commons.pacificu.edu/ptcats/59
 1 
Title: Does the Bobath/ neurodevelopmental technique (NDT) improve gait 
quality in acutely post stroke individuals?  
Clinical Scenario:  My patient was an 80-year-old gentleman who was admitted 
to the inpatient rehabilitation unit one week after sustaining a right cerebral 
vascular accident (CVA). He presented with impairments including right-sided 
weakness, left-sided inattention and left visual field cut. He was able to ambulate 
five steps in the parallel bars with moderate assistance. The patient had been 
admitted seven days prior when his wife brought him into the Emergency 
Department with slurred speech. Tissue Plasminogen Activator (TPA) was 
administered shortly after his arrival at the hospital. The patient’s wife reported 
this was his first stroke. 
Brief Introduction: Bobath Method or Neurodevelopmental Technique (NDT), 
introduced in 1987, is a popular program for stroke rehabilitation. The theory 
explains that damage to the central nervous system (CNS) causes 
neurophysiological dysfunction, which results aberrant movement patterns, but 
that neuroplastic changes can to restore normal movement. The therapists 
analyze the patient’s alignment, limit abnormal muscle tone, observe how the key 
points of the body move relative to another, and facilitate desired movement.  
 The inpatient rehabilitation unit has a high population of recovering stroke 
patients. To qualify for inpatient rehabilitation according to Medicare, a patient 
must need ongoing therapy from two or more disciplines including physical 
therapy, occupational therapy, and speech-language pathology, the patient must 
participate in 3 or more hours of daily therapy, and require a physician three or 
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more times a week (Centers for Medicare & Medicaid Services, 2014). The 
national average length of stay is 13 days with pressure from insurance agencies 
to prepare for the patient’s discharge home as quickly as possible (Report to the 
Congress: Medicare Payment Policy, 2011). The short stays place a high 
demand for physical therapists to utilize the best, and most time efficient 
interventions as possible. After working in this environment, my question is as 
follows: Is NDT more effective than conventional therapy at increasing patients 
walking ability?  
My Clinical Question: Does NDT increase the quality of gait in individuals who 
have had a recent stroke greater than standard physical therapy including 
treadmill walking and task specific exercises? 
Clinical Question PICO: 
Population: Individuals acutely post-stroke in an inpatient rehabilitation unit.   
Intervention: The intervention is the NDT method of treatment. 
Comparison: The comparison is standard physical therapy including treadmill 
walking and task oriented exercises.  
Outcomes: The components of gait including velocity, step symmetry, and 
distance in addition to the ability to perform pre-gait activities.  
 Overall Clinical Bottom Line: Based on the results of Vliet et al, Eich et al, 
Brock et al, and Dias et al, there is moderate evidence to say that NDT is equally 
as effective as standard therapy in individuals who have sustained their first 
stroke in the previous year or less in improving gait quality, ability to perform pre-
gait activities, and balance. NDT and all of the comparison methods produced 
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relatively significant within group results with scattered between group 
differences. Treatment initiation ranged from two weeks to 12 months post- 
stroke and treatments lasted from two weeks to six weeks. Results from the 
treatments tended to be equally effective in the range of chronicity of stroke. 
Outcomes used to reach this conclusion were the Berg Balance Scale, 
Rivermead Motor Assessment, Rivermead Motor Index, Movement Assessment 
Scale, six minute walk test, and ten meter walk test, all of which were found to be 
reliable and valid measures.  
All studies had good to fair internal validity. Threats across the board 
included lack of therapist and subject blinding. External validity was fair overall as 
most of the studies were initiated greater than two weeks after initial stroke 
diagnosis when inpatient rehabilitation would usually occur. Most of the NDT 
treatments were not described in enough detail for a clinician to reproduce the 
techniques. Also, most studies had small sample sizes with limited power, 
reducing the ability to generalize to other individuals one-week post CVA.  
 On a cost benefit analysis NDT certification requires a significant amount 
of therapist time but is not as expensive as the initial purchase of a treadmill or 
gait trainer equipment (British Bobath Tutors Association, 2014). Most the studies 
were feasible with insurance reimbursement in an acute rehabilitation unit, and 
feasible for patients as well. Treatments were found to be safe with no adverse 
reactions reported. Three out of the four studies had high subject retention 
indicating patients found participating tolerable in general. 
 
Search Terms: NDT/Bobath method, gait training, rehabilitation, and stroke 
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Appraised By:       
Victoria Haddad SPT 
School of Physical Therapy, College of Health Professions Pacific University 
Hillsboro, OR 97123 
 
Rational For Article Choice: A literature review was performed using the search 
terms above in the PubMed, Medline, PEDro, and CINHAHL databases. All 
seemingly relevant articles were flagged for a thorough review. The references 
were reviewed in the randomized controlled trials as well as the literature reviews 
for additional relevant articles. This process revealed nine trials whose 
hypothesis were directed toward the efficacy of NDT versus other standard 
physical therapy treatment. The articles reviewed in this paper were chosen for 
their PEDro score as determined by the website and personal evaluation, as well 
as those with the most relatable intervention comparisons and outcome 
measures (Physiotherapy Evidence Database, 1999). The four articles chosen 
for this study and a comparison of PEDro scores are: 
1. Vliet, PM van, Licoln, N.B., Foxall, A. Comparison of Bobath based and 
movement science based treatment for stroke: a randomized controlled 
trial. Journal of Neurology, Neurosurgery, and Psychiatry. 2005; 76:503-
508 
2. Eich, H.J., Mach, H., Werner, C., Hesse, S. Aerobic treadmill plus Bobath 
walking training improves walking in subacute stroke: a randomized 
controlled trial. Clinical Rehabilitation. 2004; 18: 640-651 
3. Brock, K., Haase, G., Rothacher, G., Cotton, S. Does physiotherapy 
based on the Bobath concept, in conjunction with task practice, achieve 
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greater improvement in walking ability in people with stroke compared to 
physiotherapy focused on structured task practice alone? A pilot 
randomized controlled trial. Clinical rehabilitation. 2011; 25(10) 903-912 
4. Dias, D., Lains, J., Pereira, A., Nunes, R., Caldas, J. et al. Can we 
improve gait skills in chronic hemiplegics? A randomized control trial with 
gait trainer. Clinic of Physical Medicine and Rehabilitation. 2007; 43: 499-
504 
Tables 1 and 2 show a comparison of the four articles with regard to PEDro 
scores and study parameters (Physiotherapy Evidence Database,1999) 
 
Table 1. Comparison of PEDro Scores 
 Vliet et 
al. 2005 
Eich et 
al. 2004 
Brock et 
al. 2011 
Dias et al. 
2007 
Random yes yes yes yes 
Concealed Allocation yes yes yes yes* 
Baseline 
Comparability 
yes yes yes yes 
Blind Subjects x x x x 
Blind Therapists x x x x 
Blind Assessors yes yes yes yes* 
Adequate Follow up x yes yes yes 
Intention to Treat yes yes x x 
Between Group 
Comparison 
yes yes yes x 
Point Estimates & 
Variability 
yes yes yes yes 
Total Score 7/10 8/10 7/10 6/10 * 
 
*Score reflected is different from the PEDro website  
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Table 2. Comparison of selected article PICO 
 
 
Vliet et al. Eich et al. Brock et al. Dias et al. 
Population -120 patients 
-<2 weeks post 
stoke 
- Unknown 
inpatient or 
outpatient rehab 
-50 patients 
-<6 weeks 
post stroke 
- Inpatient 
rehab 
-20 patients 
-4- 20 weeks 
post stoke 
- Inpatient and 
outpatient 
rehab 
-40 patients 
-12 months 
post stroke 
 
Intervention NDT NDT NDT plus task 
practice 
NDT 
Comparison Movement 
Based Science 
NDT and 
Treadmill 
Task Practice Gait trainer 
Dosage -23 minutes 
-5x a week 
-3 weeks 
-60 minute  
-5 x a week 
-6 weeks 
-60 minutes 
-6 sessions 
- >2 weeks 
-40 minutes 
-5x week 
-5 weeks 
Outcome 
Measure 
-Rivermead 
Motor 
Assessment 
-6 meter walk  
-Motor 
Assessment 
Scale 
-6 minute walk 
test 
-10 meter walk 
-Walking 
quality by 
Rancho Los 
Amigos 
-Modified 6 
minute walk 
test 
-10 meter walk  
-Berg Balance 
Scale 
-Rivermead 
Motor Index 
-6 minute walk 
test 
-Berg Balance 
Scale 
-10 meter walk 
Significance   None Some   Some  Within group  
   
Article 1: Vliet, PM van, Licoln, N.B., Foxall, A. Comparison of Bobath based 
and movement science based treatment for stroke: a randomized controlled trial. 
Journal of Neurology, Neurosurgery, and Psychiatry. 2005; 76:503-508  
Clinical Bottom Line: Based on 120 patients who had a stroke, NDT is not 
superior to the task practice approach of Movement Science Based (MSB) at 
improving gait speed or pre-gait tasks. Outcomes used for these conclusions 
were from the Rivermead Motor Assessment (RMA), Motor Assessment Scale 
(MAS), and Six-meter walk test (6MWT). Threats to the internal validity of the 
study were high study losses of 27%, and a lack of blinding of the subjects and 
therapists. The threat to the external validity was the poor description of the 
treatment sessions.  
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Article One PICO: 
Population: The authors studied 120 subjects, mean age of 74 years, who   
were 14 days or less post-stroke when admitted to an inpatient 
rehabilitation unit.  
Intervention: Subjects in the treatment group were treated with NDT 
therapy for as long as was needed, an average 23 minutes five days a 
week for three weeks.  
Comparison: Subjects in the control group were treated with MSB therapy 
for as long as was needed, on average 23 minutes five days a week for 
three weeks. 
Outcomes: The outcomes included one, three, and six-month 
assessments with the RMA, MAS, ten hole peg test, 6 MWT, Modified 
Ashworth Scale, Nottingham Sensory Assessment, Barthel Index, and 
Extended Activities of Daily Living Scale. Outcomes relevant to my study 
came from the RMA, MAS, and 6MWT. Other outcome measures were 
performed but are not included in this paper. 
Blinding: The subjects and therapists were not blinded to group allocation since 
the patients could see what therapy they were participating in, and the therapists 
knew what treatment they were providing. Blinding of these parties would have 
been difficult. However, the lack of blinding serves as a minor threat as there is a 
chance for Hawthorne and Rosenthal effects. The Hawthorne effect is when a 
subject acts differently when they know they are being studied and the Rosenthal 
effect is when a subject performs better because they know improvement is 
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expected. Conversely, the assessor for the one, three, and six-month 
assessments was blinded to group allocation.  
Controls: The control group received MSB therapy. The article did not describe 
treatment details but did cite a reference for the theory behind the control group’s 
exercise program. The reference explained it was rooted in systems theory that 
states in order to understand how a body moves one needs to understand the 
external forces that act upon it and is entirely task oriented training in nature. 
This seems like a valid control because conventional therapy often includes task 
practice. 
Randomization: The researchers utilized blocked computer randomization to 
place the participants into their perspective groups. The allocation was concealed 
in opaque envelopes. The randomization was successful as the groups were 
similar at baseline. However, the NDT group had higher scores on some sections 
of both the RMA and MAS at baseline that was not statistically significant. 
Study: This was an assessor blinded, randomized controlled trial. The baseline 
data for the 120 participants was gathered within two weeks of stroke onset. 
They were eligible to participate if they were referred to physical therapy and did 
not meet the exclusionary criteria. These exclusionary criteria were: unconscious 
on admission to the hospital, unable to toilet independently prior to their stroke, 
lived greater than 25 km from the hospital, unable to handle the physical tasks in 
the initial one half hour assessment, or failure to sign informed consent.   
Each group participated in their perspective therapies for a median of 23 
minutes per day, five days a week, for as long as was needed. Each patient was 
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treated on average for three weeks. The NDT therapists only treated the 
experimental group using the NDT guidelines, main concepts, and objectives, 
while the MSB therapists exclusively treated the control group using their 
theoretical framework. Outcome assessments were performed at one, three, and 
six months after randomization by a blinded assessor.  
The outcomes relevant to this review include RMA, MAS, and 6 MWT. The 
authors did not address validity or reliability of these outcome measures, 
however they did cite other studies that used these outcome tools.  An 
independent literature review found these measures to be reliable, valid, and 
responsive in stroke populations (Kurtais, 2009, Salbach 2001, Poole, 1988). 
There are no known gold standards to measure quality or quantity of gait 
parameters in stroke or healthy individuals. In the literature, the 10-meter walk 
test has an MCID of 0.16 m/s (Rehabilitation Measures Database, 2010). Since 
the 6MWT also measures velocity, it is safe to use 0.16 m/s as a guideline. 
This study lost several individuals through the course of the trial. At the 
one-month assessment, eight were lost from the NDT group and 13 from the 
MSB group. This represents a 17.5% loss. About half the losses from each group 
were due to illness. Other reasons for study losses were: five deaths, four 
refusals, and three unknown. At the three-month time point an additional nine 
were lost from the NDT group and five from MSB group. Reasons included: 
illness, death, and refusals or failures to return for assessment. At the six-month 
mark, 45 remained in the NDT group and 42 in the MSB. This represents a total 
loss of 27.5% of participants. The losses do not seem related to the treatment 
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because the initial 60 subjects in both groups completed the three weeks of 
treatment. All patients were analyzed in the group they were originally allocated 
to and all data appears accounted for. An intention to treat was performed 
because greater than 15% of participants were lost. When greater than 15% drop 
from the study there is a risk for bias as those who were not analyzed may be 
systematically different from those who were analyzed.  
Internal Validity: The internal validity is judged to be good. The patients were 
randomized into test or control groups and were not significantly different at 
baseline. The subjects and therapists were not blinded, but both groups were 
getting a treatment. The Hawthorne and Rosenthal effects potentially 
compromise the validity, but the perceived threat is deemed to be minor. The 
therapists had been treating patients with their perspective treatment styles, NDT 
or MSB, before the initiation of the study, and therefore believed their treatments 
worked. The assessor was successfully blinded. His attempt to determine which 
group based on his assessment after the intervention did not correlate well with 
their actual group assignment. The outcomes used were all reliable and valid. To 
counter the large loss of participants to follow-up, an intention to treat was 
performed. Therefore, the only threats to the internal validity of the study are 
Hawthorne and Rosenthal effects.  
A power analysis was also performed and determined that 78 participants 
were needed to demonstrate a meaningful difference of two points on the RMA.  
A total of 87 participants completed the trial, so we can be comfortable 
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concluding that there were enough participants to demonstrate a difference, if 
any, immediately after treatment or after six months post.  
Evidence: The results are presented from the “Trunk and Leg portion” of the 
RMA (Table 3), “Walking section” of the MAS (Table 4), and 6 MWT (Table 5) as 
reported from the article. Both the RMA and MAS measure the consequence of 
motor impairment in terms of mobility. The RMA has ten individual items from 
transferring from supine to sit to challenged walking. Each item is scored with a 
zero if the individual is unable to perform the task, or a one if able to complete 
the task. MAS scored from a one - six and are based on the ability to walk 
specified distances with dynamic challenges. Higher scores indicate better 
performance. In the 6 MWT an individual would walk for 6 meters (m) as quickly 
as they could to determine their gait velocity. 
Table 3: Rivermead Motor Assessment (RMA), Legs and Truck Section and Gross Motor 
Section at baseline, one, three, and six months. The RMA is scored 0-10 with 10 being 
highest function Results using a Mann Whitney U test comparing Bobath (NDT) to 
Movement Science Base (MSB) 
RMA: Legs 
and Trunk 
Baseline 1 month P 
value 
3 month  P value 6 month P value 
NDT 4 7 .61 7 .52 7 .41 
MSB 2 5  7  7  
RMA: Gross 
Motor  
       
NDT 2 7 .49 7 .18 8 .61 
MSB 1 6  8  8  
 
No raw data was given to create personal calculations. The evidence was 
compared using a Mann Whitney U test. The results are based off an Intention to 
Treat Analysis. P values were set at an alpha level of .05. An alpha of .05 means 
95% confidence that there is a difference between the groups when the P value 
is smaller than .05. 
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Table 4: Movement Assessment Scale (MAS), Walking section comparison at Baseline, 
one, three, and six months. Test is scored 0-6 with 6 being the highest function. Results 
using a Mann Whitney U test comparing Bobath (NDT) to Movement Science Base 
(MSB) 
MAS: 
Walking 
Baseline 1 month P value 3 month P value 6 month P value 
NDT 0 3 .28 3 .55 4 .27 
MSB 0 3 
 
4 
 
3 
 
 
The 6 MWT did not have baseline results, because neither group was able 
to walk according to the MAS. The MCID for the 10-meter walk test (10 MWT) is 
.16 m/s. If we use the MCID from being unable to walk in either groups, with .66 
in the NDT and .60 for MSB at one month, both groups met the MCID. 
Table 5: 6 meter walk test (6 MWT) velocity results in m/s at one, three, and six months. 
Results calculated using a Mann Whitney U test comparing Bobath (NDT) to Movement 
Science Based (MSB) 
6 MWT 1 month P value 3 month P value 6 month P value 
NDT .66 .66 .69 .87 .76 .54 
MSB .60  .64  .64  
 
The results found no significant difference between NDT and MSB at any 
of the time intervals for any of the relevant outcome tools. Therefore according to 
this study, NDT is neither a more or less effective method than MSB at 
increasing gait speed or the ability to perform pre-gait tasks.  
Applicability of study Results: 
Benefits vs. Cost: There is no additional equipment or time needed for NDT or 
MSB treatments. There is an extra expense of approximately $3,000 and about 4 
months time required of the therapist in acquiring the NDT certification (BBTA 
British Bobath Tutors Association, 2014). Each requires the same amount of 
therapist and patient time. In this study the NDT participants spent more time 
with a physical therapist assistant (PTA) with a PT present, but the MSB group 
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spent more time with the PTA alone. There were no noted adverse events in 
either treatment group.  
Feasibility of treatment: The treatments were not described in enough detail to 
replicate the study. The only assumption the reader could make was the 
therapists were treating with the method (NDT/ MSB) they were most 
comfortable with. The therapists reviewed the frameworks of their perspective 
methods, and were instructed to treat in that manner.  
The authors were vague as to whether the patients were treated in an 
inpatient or outpatient setting. The median session length of 23 minutes was 
provided with the median of three weeks of treatment. The amount of time spent 
with the patient was feasible given average insurance reimbursement for acute 
rehabilitation facilities. The treatment of 23 minutes is tolerable by the patients as 
demonstrated by no participants being lost during the three weeks of treatment.  
Summary of external validity: Because the treatment sessions were not 
described in detail, it would be hard to directly replicate the methods. The large 
number of study losses makes extrapolation difficult. It is unknown if the 
treatments caused a large number of participants to fail to comply. Also, it is 
unknown if they were being treated as inpatients or outpatients and thus would 
be less applicable to inpatient facilities if subjects were treated as outpatients. 
For these reasons the external validity is deemed fair.  
The distribution of participants is similar to the patients seen in an acute 
rehabilitation ward. A power analysis was performed and the number of 
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participants in the study was high enough to determine if there was a difference 
between treatments if one existed.  
Article Two: Eich, H.J., Mach, H., Werner, C., Hesse, S. Aerobic treadmill plus 
Bobath walking training improves walking in subacute stroke: a randomized 
controlled trial. Clinical Rehabilitation. 2004; 18: 640-651 
Clinical Bottom Line: Bobath gait training plus treadmill training (NDT +T) for 60 
minutes was found to significantly increase walking velocity and capacity in 50 
moderately affected patients who survived first time supratentorial stroke six 
week prior, than NDT gait training alone. Both groups received therapy for 30 
sessions and were assessed immediately post treatment and again after three 
months. NDT +T increased .31 m/s (+/- .30) compared to NDT alone at .16  (+/- 
.22) from baseline after treatment for walking velocity. Walking capacity was 
increased 90.6 m (+/- 43.5) for NDT +T and 55.7 (+/- 32.6) for the NDT only 
group at six weeks. The significant difference was maintained at three months for 
both outcomes. Both groups met the MCID of .16 m/s for velocity using 10 MWT 
and capacity for walking during a six-minute walk test (6 min. test) of 50 
feet.(Note, the 6 min. test is different than 6 MWT). The groups were not different 
in the RMA gross motor assessment or in walking quality. The minor threats to 
internal validity include lack of blinding to the therapists and subjects; the minor 
threat to external validity is the vague description of treatment for the NDT group. 
Article Two PICO: 
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Population: There were 50 individuals who had their first stroke within the prior 
six weeks, resided on a rehabilitation unit, and ambulated a minimum of 12 
meters.  
Intervention: The participants completed a 60-minute session of NDT 
treatment five days a week for a total of six weeks.  
Comparison: The participants in the comparison group received 30 
minutes of treadmill training plus 30 minutes of Bobath treatment five days 
a week for a total of six weeks. 
Outcomes: The patients were evaluated on their walking velocity by a 10 
MWT, walking capacity by a six min. test, the gross motor section of the 
RMA, and walking quality as outlined by Rancho Los Amigos (RLA). 
Blinding: The subjects and therapists were not blinded. Conversely, the 
assessor was blinded to group allocation during all assessment points.  The lack 
of blinding serves as a minor threat as there is a chance for Hawthorne and 
Rosenthal effects.  
Controls: One group, NDT + T, received 30 minutes of treadmill training and 30 
minutes of NDT. The other group, NDT only, received 60 minutes of NDT driven 
gait training. The single difference in treatment makes it very easy to attribute the 
differences in outcome found to the substitution of treadmill training.  
Randomization: An independent person who chose from sealed envelopes 
randomized the participants immediately prior to intervention. A total of 25 
participants were in both groups. Randomization was successful as there was no 
significant difference found between the groups at baseline.  
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Study: This study was an assessor blinded, randomized controlled trial.  
Individuals were eligible if: they were 50-75 years old, status post first time 
supratentorial stroke, less than 6 weeks post-stroke, able to walk 12 m with 
standby assistance, moderately affected with a Barthel index of 50-80, willing to 
participate in a 12-week rehabilitation program, cardiovascularly stable, having 
no other neurologic or orthopedic impairments, and able to understand the 
purpose of the study. If the inclusion criteria were met, participants were guided 
in their treatments for 60 minutes, five days a week, for six weeks. The 
experimental group received 60 minutes of NDT walking rehabilitation with pre-
gait activities, tone-inhibiting facilitation, over ground walking, and stair training.  
The control group received 30 minutes of the above NDT therapy and 30 minutes 
of treadmill training. The patient’s body weight was supported from 0% to 15%. 
The treadmill was paced and inclined in a manner in which the patient’s heart 
rate stayed at an appropriate level as determined by the Karvonen Method: 
[Target Heart Rate= ((max heart rate- resting heart rate) x % intensity) + resting 
heart rate].  
 The outcomes used for this study were 10 MWT, 6 min. walk test, the 
gross motor section of the RMA and a walking quality assessment using RLA. 
The 10 MWT was performed twice with the average time recorded. The study 
authors did not report on quality of the tool, but independent search found 
excellent inter-rater reliability, a standard measurement of error at .06, and an 
MCID of .16 m/s (Rehabilitation Measures Database, 2010). The 6 min test was 
performed one time with short breaks being allowed, but longer pauses were 
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cause to stop the assessment and record distance. The study researchers did 
not comment on the validity or reliability, but an independent search found it to be 
both with an MCID of 50 meters in stroke populations (Rehabilitation Measures 
Database, 2010). The RMA was found by an independent search to be reliable 
and valid with no MCID (Kurtais, 2009).  The walking quality assessment gave 
zero to three points for 14 items based on normal movement as described by 
RLA. The study authors reported a test- retest reliability of .87. No other 
reliability/ validity data was found on an independent search. There is no known 
gold standard for measuring gait capacity, velocity, walking quality or ability to 
perform pre-gait activities. 
 The study began with 25 participants in each group. All 50 were treated for 
six weeks with no losses. At the three-month assessment after treatment had 
concluded, one participant in the experimental group refused to follow up. This 
represents a 2% loss. All subjects were evaluated in the group they were 
allocated to. An intention to treat analysis was performed. There does not appear 
to be any missing data, nor does the one loss seem related to the intervention. 
Summary of internal validity: This study was judged to have good internal 
validity. This was a randomized controlled study, the assessors were blinded, 
and the subjects were similar at baseline. Most outcome tools were reliable and 
valid, there were few study losses, and an intention to treat was performed. The 
threats to internal validity were Hawthorne and Rosenthal effects because the 
subjects and therapists were not blinded. These threats are deemed to be minor 
because the subjects did not know which treatment is believed to be superior, 
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and the therapists provided quality treatment to both groups. No power analysis 
was performed so it is unknown if the number of participants was enough to 
demonstrate significance.  
Evidence: The data from all four-outcome measures used at the end of the six-
week treatment and at the three-month assessment are relevant to this review. 
The NDT +T group was found to walk significantly faster than the NDT only group 
at the end of six weeks of treatment and at three months as shown by Table 6. 
There was an increase of .31 m/s in the NDT + T group while the NDT only group 
increased .16 m/s. Both groups did meet the MCID of .16 m/s. The NDT + T 
group shows a medium effect size of .42 with a Confidence Interval (CI) ranging 
from -0.014- +0.98. The CI crossing zero suggests if the study were to be 
repeated, NDT only group may be found to be more effective. At three months, 
the change in NDT + T group velocity was .36 m/s from baseline while the NDT 
only group decreased one m/s from the six week mark. Numbers presented in 
Table 6 were transposed from the study while effect sizes were derived on 
independent calculation. 
Table 6: Walking velocity as determined by the 10 meter walk test 
Treatment 
Group 
Baseline 6 weeks Between 
group 
3 months Between 
group 
NDT (m/s) .44 (+/- .22) .60  (+/- .22) 
 
.58 (+/- .22) 
 
NDT+ 
Treadmill 
(m/s) 
.40 (+/- .17) .71 (+/- .30) 
 
.77 (+/- .35) 
 
Between 
Group 
Comparison 
  
F = 12.6 
Significant 
<.001 
 
F= 15.9 
Significant 
<.001  
 
Table 7 depicts the significant difference between the NDT + T group over 
NDT only group in walking capacity in six minutes at the end of treatment period 
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and at three months. The NDT + T group had a change score of 90.6 meters 
while the NDT only group increased by 55.7 meters. This demonstrates a 
medium effect size of .45. The CI ranges from -.11 – 1.01, which indicates the 
study results could be opposite if repeated. At three months, distance walking 
dropped one m in the NDT only group and continued to increase 26 meters in the 
NDT +T group. The MCID for the 6 min. test in stroke populations was found to 
be 50 m and both groups met the cut off (Rehabilitation Measures Database, 
2010).  
Table 7: Walking capacity as determined by the 6 minutes walk test 
Capacity 
(meters) 
Baseline 6 weeks Between 
group 
3 months Between 
group 
NDT 108 (+/- 60.1) 164.4 (+/- 69.3) F = 10.3 163.0(+/- 70.2) F= 18.7 
NDT+ 
Treadmill 
108.1 (+/- 50.8)  198.8  
(+/- 81.1) 
Significant 
P= .002 
224.8(+/- 90.0) Significant 
P < .001 
 
Tables 8 and 9 portray the results from the RMA gross motor section and walking 
quality. There were no significant differences found at six weeks or at three months 
between the groups. 
Table 8: Gross motor function of Rivermead Motor Assessment scored 0-13  
RMA gross 
motor 
Baseline 6 weeks Between 
group 
3 months Between 
group 
NDT 9 (6-10) 11 (10-11) no 11 (10-11) no 
NDT+ Treadmill 9 (7-10) 11  significant 11 significant 
 
Table 9: Walking Quality as outlined by Rancho Los Amigos 14 items scores 
range 0-41 
Walking 
Quality 
Baseline 6 weeks Between 
group 
3 months Between 
group 
NDT 19 (15-23) 24 (19-29) No  23.5 (11.3- 
29.8) 
no 
NDT+ Treadmill 18 (15-24) 24 (18-27) significant 24 (19-30) significant 
 
Applicability of study results: 
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Benefits vs. Costs: The treatments were similar in the amount of therapist and 
patient time, neither group had an adverse event, and both groups reached the 
prospective MCIDs. However, the costs of the interventions and outcomes were 
different. NDT +T was found to have significant results over NDT only group in 
increasing walking velocity and capacity, but at a large cost. NDT certification is 
expensive for the therapist as discussed previously, but supported treadmill 
training has additional investment. While most participants did not need body 
weight support, the machine can cost $12,000 plus $4,000 for the treadmill 
(Technology for Long-Term Care, 2010). The cost may be worth the increased 
benefit received from NDT +T.  
Feasibility: The amount of daily therapy relates well with inpatient rehab and 
should be fairly easy for patients to tolerate. However, the 30-day stay is twice 
the typical length of stay for an inpatient at present (Report to the Congress: 
Medicare Payment Policy, 2011). Many rehabilitation units are equipped with 
supported treadmill training and NDT certified therapists. The treatment had no 
adverse events and is not dependent on patients practicing on their own. The 
downfall was that the NDT only treatments were not described thoroughly. 
Although, the NDT treatments were described with minor detail, there is still not 
enough information to repeat the study. 
Summary of external validity: The internal validity does not compromise the 
ability to extrapolate to other populations. The study only included supratentorial 
strokes, with moderately affected patients who were younger in age, which limits 
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the applicability of the results. It is unlikely that many patients would be 
authorized to stay for four weeks to receive 30 sessions of therapy.  
Article Three: Brock, K., Haase, G., Rothacher, G., Cotton, S. Does 
physiotherapy based on the Bobath concept, in conjunction with task practice, 
achieve greater improvement in walking ability in people with stroke compared to 
physiotherapy focused on structured task practice alone? A pilot randomized 
controlled trial. Clinical Rehabilitation. 201; 25(10) 903-912 
Clinical Bottom Line: Based on 26 individuals who sustained a stroke 20 weeks 
prior to entering the study, six treatments of NDT over two weeks works better at 
improving gait velocity in a 10 MWT than task practice. The effect size was .7 
indicating a moderate effect. The task group received repeated strengthening 
exercise and practiced challenged walking for dosage-matched treatments with 
verbal, but without hands-on, feedback from the therapists. There were no 
significant differences in adapted six min. test or BERG Balance Scale (BBS). 
Only the NDT group however met the MCID for the 6 min test of 50 m. The minor 
threats to the internal validity of the study were the lack of blinding of the patients 
and therapists yielding a fair to good external validity due to the questionable 
power of the study.   
Article Three PICO: 
Population: This study included 26 participants who were four -20 weeks 
post-stroke and were able to ambulate with supervision. 
Intervention: The intervention was six one-hour NDT sessions geared 
toward walking including ten minutes of task practice.  
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Comparison: The control group received six one-hour sessions of task 
practice focusing on endurance and dynamic balance and walking. 
Outcome: Progress was determined by an adapted six min. test utilizing a 
ramp, step, and a foam compliant surface, BBS, and walking velocity.  
Blinding: The subjects and therapists were not blinded to group allocation, 
which is difficult to do in therapy research. However, the lack of blinding serves 
as a minor threat as there is a chance for Hawthorne and Rosenthal effects. 
Conversely, the assessor was blinded to group allocation during all assessment 
points thereby avoiding rater bias.  
Controls: The control group had six, one-hour sessions of focused task practice. 
Therapists provided feedback on the performance of tasks, but did not provide 
hands-on guidance. Half the sessions included repetitive exercises on gym 
equipment, and the second half was outside walking on ramps, steps, and rough 
surfaces. This serves as an adequate comparison as the intervention is similar to 
standard therapy; however, therapists would usually provide tactile feedback and 
assistance.  
Randomization: The randomization was computer generated and stratified 
according to the interval of time from stroke onset to participation in the study. 
This is an appropriate stratification. Opaque envelopes concealed the allocation 
of groups. Randomization was deemed successful since the groups were similar 
at baseline. 
Study: This was a single blind, randomized control trial including 29 subjects. 
Participants were eligible for inclusion if they had a stroke four - 20 weeks prior to 
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trial commencement, were currently enrolled in a rehabilitation program, and able 
to walk five meters indoors. The exclusionary criteria included independent 
ambulation, pre-morbid household only ambulation, unable to follow single verbal 
commands, and movement disabilities caused by a non-stroke diagnosis.  
 The experimental group received NDT treatment by NDT certified 
therapists to facilitate normal, efficient, and functional movement strategies 
geared toward walking. Approximately ten minutes of each session was spent on 
structured task practice. There were six treatments total lasting one hour, over 
two weeks. The control group received the same number and duration of 
treatments, but focused on therapeutic exercise on gym equipment and dynamic 
and challenge walking outdoors.  
Outcome measure: The main outcome measure utilized in this study was the 6 
min test including a 1:6 ramp, a 160 mm step, and 1.1 meter long firm foam mat. 
The researchers did not report on the validity for this modified six min. test, but 
did state the test- retest reliability was .98. On an independent literature review, 
the six min. test was found to be reliable and valid with an MCID in stroke 
populations of 50 feet (Rehabilitation Measures Database, 2010). This MCID is 
applied with caution given the study used a highly modified version. 
 Other outcome tools included the BBS and 10 MWT. Both were reported 
by the authors to be reliable and valid. There is no established MCID for the 
BBS, but the minimal detectible change (MDC) for stroke populations is 3 
(Rehabilitation Measures Database, 2010). The cut off score for safe 
independent ambulation is 45/56 (Rehabilitation Measures Database, 2010). The 
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10 MWT MCID for velocity is .16 m/s (Rehabilitation Measures Database, 2010). 
Ambulation slower than .4 indicated household ambulation only. Velocity above 
.8 indicates the ability for community ambulation.  
Study losses: Three participants were lost during the course of the study. The 
NDT group lost two with an early discharge, and one from the task practice group 
due to illness. The study losses do not appear to be related to the interventions. 
This is less than a 15% study loss.  
Summary of Internal Validity: This study was judged to be good. The 
participants were randomly allocated to either an experimental group or a control 
group to protect from statistical regression, selection, inter-subject differences, 
history, and maturation. The assessor was blinded protecting from rater bias. 
Four minor threats exist including Rosenthal and Hawthorne effects, not all 
outcomes were valid, and no intention to treat analysis was performed. The 
modified six min. test has face validity, but none officially proven. This is minor, 
as the other outcome measures have been shown to be reliable and valid. An 
intention to treat analysis was not performed, however, all participants were 
analyzed in the group they were randomized into. This study was underpowered 
as reported by the authors and therefore it may be difficult to show a difference, 
even if one exists.  
Evidence: Assessments were performed on the subjects before and after the 
two- week intervention period. Table 10 outlines the scores pretest and posttest 
for both groups as detailed in the study. There were no significant differences 
found between the groups either before or after the treatments for the modified 
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six min. test and BBS. However, velocity was significantly increased in NDT 
group over the task practice group. A self calculated effect size was determined 
to be .7 that is indicative of a medium to large effect. However, the CI ranges 
from -.06 to 1.53 meaning if the study was repeated, it would be possible that the 
results could be reversed.  
Table 10: Pre and post intervention outcome results 
 
NDT  
Pre 
NDT  
Post 
P 
Value 
Task 
Pre 
Task 
Post 
P 
Value 
Between 
Group 
Adapted 6 
min. (m) 
102.6 
+/- 64.5 
192.5  
+/- 113.5 
<.01 78.5 
+/- 61.3 
119.5 
+/- 80.2 
<.01 .07 
Velocity 
(m/s) 
.51 
+/- .27 
.94 
+/- .47 
<.001 .44+/-
.32 
.60 
+/-. 47 
<.02 .01 
BERG 40.2 
+/-  6.1 
47.3  
+/- 4.6 
<.001 43.3 
+/- 5.7 
47.4  
+/-5.0 
<.01 .2 
 
  Both groups had significant within group changes for all outcome 
measures. Only the NDT group had a greater than the MCID of a 50 meter 
increase for the adapted six min. Both groups increased by .16 m/s meeting the 
MCID for the six min. test. Both groups reached the cut off score of 45/56 on the 
BBS assessment thereby decreasing their fall risk.  
Applicability of Study Results: 
Benefits vs. Costs: The frequency of treatment in this study was significantly less 
than in other studies in this review thereby being financially conservative for the 
patient by requiring fewer copays. Both groups received the same amount of 
patient and therapist time, although the task practice group received less hands-
on time. No adverse events were noted in either group. The therapist in the 
experimental group was NDT certified. Treatment with NDT did produce 
significantly better between group changes in velocity, but not in the adapted 6 
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min group or BBS. The task practice group carried low cost because all 
equipment needed would be at a local gym or in a physical therapy clinic.  
Feasibility of treatment: There were a total of three one-hour treatments per 
week. This is significantly less physical therapy than the patients would receive in 
a rehabilitation unit. However, the total treatment lasted two weeks, which is quite 
comparable to a typical rehabilitation unit stay and reimbursable by insurances. 
The two treatments were described in greater detail than the previous studies 
and would easily be reproducible. There was no home exercise program, so 
compliance would not be an issue. The treatment was not painful for the patients.  
Summary of external validity: The external validity was deemed fair to good. The 
underpowered sample size of 26 challenges one’s ability to extrapolate to other 
populations of stroke survivors as such a small sample may not accurately 
represent the greater population. However, the study had good internal validity, 
the researchers used a strict protocol and appropriate statistical tests. Therefore 
the results can be cautiously applied to individuals who fit the inclusionary and 
exclusionary criteria.  
Article Four: Dias, D., Lains, J., Pereira, A., Nunes, R., Caldas, J. et al. Can we 
improve gait skills in chronic hemiplegics? A randomized control trial with gait 
trainer. Clinic of Physical Medicine and Rehabilitation. 2007; 43: 499-504 
 
Clinical Bottom Line: In subjects that are one year post-stroke without other 
impairments that effect walking, there is questionable evidence to say that NDT 
is no better than using a gait trainer in increasing BBS, Rivermead Mobility Index 
(RMI), six min. test, and step length and cadence scores after 40 minute 
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sessions five times a week for five weeks. Step length and step cadence 
continued to improve three months post-treatment in the NDT group, while the 
BBS improved in the gait trainer group. The internal validity was deemed good 
with the only threats being the Rosenthal and Hawthorne effects. However, the 
external validity was poor as subjects were one year or greater after stroke, the 
study did not mention how many participants were needed to show power, and 
no between group comparisons were made. The treatments seem to exceed 
insurance reimbursement but the time constraints were manageable in both 
groups for the patients and the therapists.  
Article Four PICO: 
Population: This study included 40, 18-80 year olds who had been 
diagnosed with their first stroke over one year prior to the study 
commencement and who had no rehabilitation in the past six months. 
Intervention: Participants were treated for 40 minutes, five times a week 
for five weeks with 20 minutes of NDT and 20 minutes of stretching and 
strengthening. 
Comparison: The control treatment received gait training with REHA- 
STIM trainer for 20 minutes, five times a week for five weeks with 20 
minutes of stretching and strengthening.  
Outcomes: This study evaluated the participants’ progress with Motricity 
Index, Toulouse Motor Scale, Modified Ashworth Spasticity Scale, BBS, 
RMI, Fugl-Meyer Stroke Scale, Functional Ambulation Category, and Step 
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test. The BBS, RMI, 10 MWT, and six min. test were relevant to my review 
and are presented in the following paragraphs. 
Blinding: This was a single blind study with only the assessors unaware of the 
participants’ allocation. This serves as a minor threat since the therapist might 
have treated the patients in the groups differently because they knew what the 
hypothesis was. Also the patients knew which treatment they were getting and 
their motivation may have been effected.  
Controls: The control group received part of their therapy on the REHA- STIM 
trainer. It consists of two footplates that the patient stands on that simulate swing 
and stance phase of gait with a harness that suspends the patient. A motor 
assists in movement by regulating the velocity and center of mass of the patient.  
The patient’s body weight was never suspended greater than 30% and was 
reduced in subsequent sessions. A physical therapist was needed to correct 
knee motion when necessary. The second half of the treatments consisted of 
joint mobilization and muscular strengthening.  
Randomization: The participants were placed into their group by permuted-
block randomization. Only an administrative secretary knew of the allocation of 
the patients, the researchers did not. The randomization was successful as the 
groups were similar at baseline.  
Study: This was a randomized control trial with assessor blinding including 20 
participants in both the experimental group and the treatment group. The 
inclusion / exclusion criteria were a first time stroke, chronic stage with 12 
months since onset, motor stabilization, lower limb motor deficit, between the 
 29
ages of 18-80, cognitive state of greater than 19 on the mini mental state exam, 
communication skills necessary to understand treatment, absence of other 
medical conditions that would interfere with test results, and no rehabilitation 
management in the previous six months.  
The experimental group, NDT group, received 40 minutes of treatment five 
times a week for five weeks. The first 20 minutes of their sessions included NDT 
focused gait training and balance exercises. The remaining 20 minutes included 
similar joint mobilizations and muscular strengthening as the control group 
received. The control group, trainer group, treatment was as described above. 
Outcome measures: The authors reported that the RMI, BBS, 10 MWT, and six 
min. test have all been found to be reliable and valid although no inter-rater or 
intra- rater reliability was reported. There is no gold standard for measuring 
balance or gait abilities. The RMI is an extension of the RMA gross motor section 
that was utilized in an earlier in this paper. Included in the RMI are 15 items 
scored from zero (unable to perform), to one (being able to perform). On an 
independent search, it was found to have a MDC of 2.2 points (Rehabilitation 
Measures Database, 2010). As discussed earlier, the BBS has a fall risk cut off 
score of 45/56 with an MDC that varies depending on their initial score, but is 
around three. The 10 MWT MCID for velocity is .16 m/s; no data could be found 
on cadence. The 6 min. test MCID has been found to be a 50 meter increase.  
Study losses: The article does not report any study losses. No data appears to 
be missing. There was no intention to treat analysis performed. All subjects were 
evaluated in the group they were originally randomized into.  
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Summary of Internal Validity: The internal validity was judged to be good. The 
study was randomized, controlled, single blind, and the subjects were similar at 
baseline. There was no intention to treat performed, but that is not a threat as no 
participants were lost. The only minor threats to the validity are the Rosenthal 
and Hawthorne effects because the therapists and patients where not blinded. It 
is very difficult to avoid these threats in physical therapy research. No power 
analysis was performed, therefore it is unknown if a change will be detected with 
statistical tests even if one is truly exists. 
Evidence: The two groups were analyzed using T tests. The researchers only 
reported within group changes and did not present data that did not have 
significant results at either initially post-treatment or at three months post-
treatment. From a visual inspection, there does not appear there would be any 
between group differences. Table 11 outlines the relevant outcomes for the NDT 
group and Table 12 for the gait trainer group.  
Table 11. NDT group change scores after five weeks of treatment, and three 
months after treatment ended with T- Test results. X indicates no significance. 
 Post Treatment 
Change Score 
T- Test 3 months 
Change Score 
T- Test 
BBS 3.42 +/- 6.69 .039 1.42 +/- 4.00 x 
RMI 1.26 +/- 1.82 .007 .16 +/- .90 x 
Step cadence .01 +/- .15 x 14.94 +/- 23.20 .017 
Step length 2.11 +/-18.51 .017 18.52 +/- 29.41 .019 
6 min test 23.28 +/- 2.33 .001 .56 +/- 22.65 x 
 
The NDT group had significant within group changes in the BBS, RMI, 
step length, and 6 min. test initially after treatment. There were no differences 
found for velocity or step cadence initially. However, step cadence and step 
length were significantly different at three months post-treatment compared to 
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initially post-treatment. None of the outcomes reached a significant MCID. The 
gait trainer group had significant results in all categories following the five-week 
treatment. However, only the BBS score improved significantly three months 
after treatment cessation. None of the outcome tools reached their MCID. 
Table 12. Gait Trainer group change scores after five weeks of treatment, and 
three months after treatment ended with T- Test results. X indicates no 
significance.  
 Post Treatment 
Change score 
T- Test Three months 
change score 
T- Test 
BBS 3.90 +/- 6.53 .015 1.65 +/- 1.90 .001 
RMI .35 +/- .75 .049 1.35 +/- 3.38 x 
Step cadence 11.06 +/- 23.84 .041 16.52 +/- 47.12 x 
Step length 13.33 +/- 21.88 .013 18.50 +/- 45.03 x 
6 min. test 18.92 +/- 26.33 .005 9.88 +/- 34.80 x 
 
Applicability of study results: 
Benefits vs. Cost: Both groups received dosage-matched treatments. The 
number of treatments was high in this study with the least amount of change in 
the groups’ outcome scores compared to other articles reviewed. The financial 
costs of the trainer is quite high, as discussed with the body weight supported 
treadmill training. The treadmill training does not require extra certification unlike 
NDT. The cost to become a certified NDT therapist requires significant time on 
the therapist. There were no adverse events reported in either of the treatment 
groups. 
Feasibility of treatment: The NDT treatments were not well described and would 
be difficult to reproduce. The gait training was outlined clearly and would be 
easier to follow. The total of 25 sessions is beyond the average initially approved 
12 sessions by Medicare for outpatient therapy (Centers for Medicare and 
Medicaid Services, 2014). This estimate is based off the average cost of therapy 
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at 90 dollars a session (Edgar, 2011), and the therapy cap of 1,920 dollars that is 
split between Speech-Language Pathology for a calendar year (Centers for 
Medicare and Medicaid Services, 2014). However, 40 minutes is feasible for both 
the therapist and the patient. There is no reliance on a home exercise program. 
The treatments were not painful. 
Summary of external validity: The external validity was deemed to be fair. There 
was questionable power due to the fact there was no power analysis performed 
for this study. This study had a limited ability to assist in answering the question 
in the clinical question. The participants all had a diagnosis of chronic stroke, and 
therefore are very much unlike the patient in the clinical scenario. Otherwise the 
study had high enough internal validity to be extrapolated to patients who have 
had a stroke over a year, as there was a strict protocol for the study and 
appropriate statistical tests were used.  
Synthesis: 
Based on the results of the reviewed research studies, in patients two 
weeks post stroke diagnosis, it appears NDT is equally effective at improving gait 
and pre-gait abilities as other physical therapy interventions such as task practice 
and standard gait training. The results support this conclusion as two of the four 
studies reviewed found a lack of between group differences and the other two 
studies failed to reveal anything more than scattered significant differences 
between the groups in various outcome assessments.  
      The Vliet et al. study was strong because it contained the highest number 
of subjects who were most comparable to the patient in the clinical scenario in 
 33
length of time elapsed since stroke diagnosis.  This study also provided a total 
number of treatments most similar to the number allowed in our present 
healthcare reimbursement environment.  The Eich et al. study had the highest 
quality methodology based on its PEDro score.  The duration of each individual 
treatment session was also most comparable to average treatment times 
provided in an acute rehabilitation setting. The Brock et al. study had the least 
number of subjects and the fewest total number of treatment sessions. The 
subjects were, however, treated for two weeks which is very comparable to a 
typical length of stay for an acute rehab stroke patient.  The Dias et al. study 
appears to be the weakest study in the review due to their subjects, treated one-
year post stroke diagnosis, being the least like the patient in the clinical scenario.  
According to its PEDro score, it also had the poorest quality methodology.      
      Each study provided different treatments to their non-NDT comparison 
group that limits one’s ability to draw a cumulative conclusion on the 
effectiveness of NDT over other physical therapy interventions. All the 
comparison group interventions were, however, typical treatment approaches 
commonly considered to be components of standard physical therapy geared 
toward improving gait and pre-gait functions. Therefore, the variety of treatments 
provided is deemed sufficient to reveal the comparative efficacy of the NDT 
approach for rehabilitation. 
     In the reviewed studies, the most common flaw was an imprecise description 
of the treatments provided to comparison group subjects.  The studies’ 
descriptions were insufficient to allow additional researchers to validly duplicate 
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or challenge their results and findings.  Internal validity of these types of research 
studies would improve if appropriate methods of blinding both patients and 
therapists could be accomplished.  Since each of these studies had a low 
number of participants, the strength of their research would be improved if they 
had investigated a greater number of subjects or performed a power analysis to 
ensure if enough participants were tested. Future research could focus on 
standardizing a quality of gait assessment as attempted by Eich et al. using 
Rancho Los Amigos scale.    
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